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Abstract: Impairment of the intestinal barrier is one of the key events in the initiation of the
sensitization process in food allergy. The aim of this study was to explore the effects of kiwifruit
allergen Act d 1 on intestinal permeability and tight junction protein (TJP) gene expression in vivo
and to explore its potential to activate the NF-kB signaling pathway and to regulate expression of
epithelial pro-allergenic cytokines. Influences of Act d 1 on TJP gene expression and pro-allergenic
cytokines in the mouse intestine was analyzed by qPCR upon allergen administration by oral gavage.
The effect on the in vivo intestinal permeability was assessed in ELISA by measuring the translocation
of β-lactoglobulin (BLG) into circulation. The capacity of Act d 1 to activate the NF-kB pathway was
tested in HEK293 cells by fluorescent microscopy and flow cytometry. Administration of Actinidin
(Act d 1) increased intestinal permeability to the BLG. This was accompanied by changes in gene
expression of TJP mRNA and pro-allergenic cytokines IL-25, IL-33, and thymic stromal lymphopoietin
(TSLP) compared to the control. Act d 1 reduced TEER of the HEK293 monolayer, was positive in an
NF-kB-reporter HEK293 cell assay, and induced secretion of TSLP. These findings shed more light
on the molecular events in the sensitization process of kiwifruit but possibly also of other protease
food allergens.
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1. Introduction
The prevalence of food allergies has significantly increased and become a substantial health
burden in developed countries [1]. A range of clinical manifestations affecting the gastrointestinal (GI)
tract, skin, and lungs has been related to food allergy [2]. One of the main mechanisms underlying food
allergy involves the breakdown of the GI barrier and immunological tolerance against ingested food
allergens [1,3]. A pivotal role of the GI barrier is the maintenance of intestinal homeostasis and the first
line of defense against various mechanical, chemical, and microbial stressors from the environment,
including natural antigens occurring in food [4]. The capacity of epithelial cells to receive and decode
signals from the environment and to employ received information in regulation of the responses of
immune cells is critical for the maintenance of immune homeostasis [5].
In murine models of food allergy, oral exposure to antigen and an adjuvant stimulates gut epithelial
cells to express the innate pro-allergenic IL-33, IL-25, and thymic stromal lymphopoietin (TSLP), which
contribute to the development of acute reactions to food and promotion of Th2 response [1,6–8].
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The integrity of the intestinal barrier and epithelial cells is maintained by intercellular junctional
complexes composed of tight junctions (TJs), adherens junctions, and desmosomes. TJs are complex
structures composed of more than 40 proteins, which represent signaling platforms that establish cell
polarity, transmit signals into nuclei, and modulate gene expression [9]. Among a range of proteins that
are connected to a junctional plaque, Rho GTPases are central components of signaling pathways that
guide junction assembly and polarization as well as are involved in the mechanisms by which junctions
transmit a signal to the cell interior [10]. Distinct Rho proteins have been involved in the regulation of
the NF-kB transcription factor, which is involved in preserving intestinal immune homeostasis and
has a role in the development of inflammatory intestinal diseases [11,12]. Activation of the NF-kB
signaling pathway and release of epithelium-derived IL-33, TSLP, and IL-25 are observed in airway
epithelium during the initiation of type 2 immune response in respiratory mucosa [13] and in food
allergy [14]. The above would suggest that there is a direct link between TJ functionality, NF-kB, and
sensitization. However, there is no evidence linking these sensitization events to kiwifruit allergens
and NF-kB signaling pathway, so far.
Since 1981, there has been an increasing number of reports on kiwifruit allergy. It has become
evident that kiwifruit allergy is frequently associated with grass and birch pollen allergies [15,16].
Children, however, are often mono-sensitized to kiwifruit, suggesting a role of primary digestive tract
sensitization [17]. Thirteen allergens have been identified in kiwifruit (www.allergen.org), but cysteine
protease Actinidin (Act d 1) is considered the major allergen, representing 50% of the total soluble
protein content [16].
The aim of this study was (i) to evaluate the effects of Act d 1 on the TJ proteins in terms of their
mRNA expression in mice intestine, (ii) to analyze mRNA expression levels of IL-25, IL-33, and TSLP
in vivo and in vitro, and (iii) to test the potential of Act d 1 in activating NF-kB signaling pathway.
2. Materials and Methods
2.1. Allergen Preparation
Actinidin (Act d 1) was purified from fresh kiwifruit by two consecutive ion-exchange
chromatographies as previously described [18,19]. The purity of the protein preparation was estimated
to be >97% as observed by SDS–PAGE. The proteolytic activity of the purified enzyme was determined
by using an enzymatic assay with casein [20]. Before the treatment, Act d 1 was either activated
in cell culture medium for 1 h at 37 ◦C for in vitro experiments or with 0.2 mM cysteine for in vivo
experiments. For inactivation, cysteine protease inhibitor E-64 (Sigma-Aldrich, St. Louis, MO, USA)
was added to the Act d 1 solution in an equimolar ratio (v/v).
2.2. Animals
C57BL/6 mice (n = 6/group) (Charles River Laboratories, Maastricht, The Netherlands) were
housed under controlled conditions in standard laboratory cages. All in vivo experiments were
approved by the Ethics Committee for Animal Experiments (AVD108002016394) and were performed
in compliance with governmental and international guidelines on animal experimentation.
2.3. The Dosage Regimen of Act d 1 and Permeability Assay
The effect of Act d 1 on the in vivo permeability across the intestinal mucosa was assessed
by measuring the translocation of β-lactoglobulin (BLG) into mouse circulation upon oral gavage.
A control group of mice (n = 6) received 350 µL of PBS with 0.2 mM L-cysteine. The second group
(n = 6) received 350 µL of E-64 inactivated Act d 1 (5 mg/mL in PBS), and the third group (n = 6)
received active Act d 1 350 µL (5 mg/mL in PBS) by oral gavage. After 24 h, mice from all three groups
received BLG by oral gavage (500 mg/kg BW). Blood samples (~150 µL) were drawn from the cheek
vein 30 min after BLG administration. Following centrifugation (3000× g, 10 min), sera were collected
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and diluted 1:1 (v/v) in PBS. ELISA capture was performed for quantification of BLG in mice sera
according to the manufacturer’s instructions (Bethyl Laboratories, Inc., Montgomery, TX, USA).
2.4. Isolation of RNA and qRT-PCR of Mouse Intestinal Samples
For mRNA studies, the mouse intestine was flushed with cold PBS and separated into the following
segments: proximal small intestine (first centimeter of the proximal part of the jejunum, 2 cm after
the stomach) and distal small intestine (final centimeter before the ileum–caecum–colon junction) and
colon. These intestinal samples (1 cm) were snap-frozen in liquid nitrogen and stored at −80 ◦C. Total
RNA was extracted from each tissue sample (50 mg) using TRI Reagent® and homogenized using a
tissue lyser (Qiagen, Hilden, Germany) for 1 min at 25 Hz. The complementary DNA (cDNA) was
prepared from total RNA (2 µg) by using random primers and MultiScribe™ Reverse Transcriptase
from the High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA).
Gene expression analysis was assessed by quantitative real-time PCR (qRT-PCR). PCR reactions were
performed using the ABI Prism 7500 Sequence Detection System (Applied Biosystems, Foster City,
CA, USA). The reaction mixture for the qRT-PCR, containing 1 µL undiluted cDNA and 5 µL Maxima
SYBR Green/ROX qPCR Master Mix (2×) (Thermo Fisher Scientific, Waltham, MA, USA), forward
and reverse primers (final concentration of 300 nM for each primer), and sterile deionized water, was
prepared according to the manufacturer’s instructions. PCR cycle parameters were as follows: general
denaturation at 95 ◦C for 3 min, 1 cycle, followed by 40 cycles of 95 ◦C for 20 s, annealing temperature
(AT) for 30 s, and elongation at 72 ◦C for 30 s. Gene-specific primers for CLDN1, CLDN2, CLDN3,
CLDN4, OCLN, ZO protein 1 (ZO1), E-cadherin, IL-25, IL-33, and TSLP, (Table 1) were derived from
the U.S. National Center for Biotechnology Information (NCBI, Bethesda, MD, USA) GenBank and
were purchased from Invitrogen (Paisley, UK). The mRNA quantity was calculated relative to the
expression of the reference gene (β-actin) and analyzed by the delta-delta-Ct method.
Table 1. Murine primer sequences used in qRT-PCR.
Target Gene (Reference) Murine Primer Sequence (5′–3′) Tm (◦C)
CLDN1 (NM_016674.4) F: TCTACGAGGGACTGTGGATG 57R: TCAGATTCAGCTAGGAGTCG
CLDN2 (NM_016675.4) F: GGCTGTTAGGCTCATCCAT 55R: TGGCACCAACATAGGAACTC
CLDN3 (NM_009902.4) F: AAGCCGAATGGACAAAGAA 58.7R: CTGGCAAGTAGCTGCAGTG
CLDN4 (NM_009903.2) F: CGCTACTCTTGCCATTACG 55R: CTGGCAAGTAGCTGCAGTG
OCLN (NM_008756.2) F: ATGTCCGGCCGATGCTCTC 61.2R: TTTGGCTGCTCTTGGGTCTGTAT
ZO1 (NM_009386.2) F: CGAGGCATCATCCCAAATAAGAAC 58.7R: TCCAGAAGTCTGCCCGATCAC
E-cadherin (NM_009864.2) F: ACTGTGAAGGGACGGTCAAC 64.3R: GGAGCAGCAGGATCAGAATC
IL-33 (NM_001164724.1) F: GGTGTGGATGGGAAGAAGCTG 61R: GAGGACTTTTTGTGAAGGACG
TSLP (NM_021367.2) F: CGGATGGGGCTAACTTACA 61R: TCCTCGATTTGCTCGAACTT
IL-25 (NM_080729.3) F: CAGCAAAGAGCAAGAACC 61R: CCCTGTCCAACTCATAGC
ACTB (NM_007393.3) F: ATGCTCCCCGGGCTGTAT 61R: CATAGGAGTCCTTCTGACCCATTC
2.5. HEK293 Cell Culture, RNA Isolation, and Gene Expression Analysis
Human embryonic kidney epithelial HEK293 adherent cells (passages 15–25) were cultivated
in Minimum Essential Medium (MEM, Sigma-Aldrich, St. Louis, MO, USA) supplemented with
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10% heat-inactivated fetal bovine serum (FBS), penicillin (100 IU) and streptomycin (100 µg/mL)
(Sigma-Aldrich, St. Louis, MO, USA) and in 200 mM L-glutamine (Sigma-Aldrich, St. Louis, MO, USA)
in an atmosphere of 5% CO2 at 37 ◦C. Cells passaging were performed by using 1 × trypsin/EDTA
solution (Sigma-Aldrich, St. Louis, MO, USA). Each experiment contained untreated monolayers as
control to allow normalization of the data and statistical analysis.
For transepithelial electrical resistance (TEER) measurement, HEK293 cells (0.6 × 105 cells per
well) were grown on polycarbonate cell culture inserts (0.4 µm diameter pore) in 24-well plates (Nunc,
Roskilde, Denmark) at 37 ◦C in 5% CO2. The cells were allowed to grow for three days to reach
80–90% confluence. The cell monolayers were treated either with activated Act d 1 (1 mg/mL) or
with E-64-inactivated Act d 1 (1 mg/mL) as previously described [21]. Act d 1 samples were applied
onto the apical side of the cell monolayer, and TEER was measured by using a Millicell ERS meter
(Millipore, Bedford, MA, USA). The results represent mean± standard error (SEM) of three independent
experiments. Untreated HEK293 cell monolayers were used as control.
HEK293 cells were seeded at density 0.2 × 106 cells/well (12 well plate) and cultivated. Before the
Act d 1 treatment, cells were washed with PBS and incubated in serum-free medium for 1 h. Cells were
treated with activated or inactivated Act d 1 (1 mg/mL) for 6 h. Thereafter, the medium was removed
and cells were washed with cold PBS and collected by centrifugation (800 rpm, 7 min). Isolation of
RNA and evaluation of gene expression were performed as previously described [21]. GAPDH was
used as a housekeeping gene to allow normalization of mRNA levels between samples. Gene-specific
primers for human genes are listed in Table 2.
Table 2. Human primer sequences used in PCR.
Target Gene (Reference) Human Primer Sequence (5′–3′) Tm (◦C)
TSLP (NM_009903.2) F: CGCTACTCTTGCCATTACG 55R: ACTCAGCACACCATGACTTG
IL-25 (NM_022789.3) F: CCAGGTGGTTGCATTCTTGG 49R: TGGCTGTAGGTGTGGGTTCC
IL-33 (NM_033439.3) F: CACCCCTCAAATGAATCAGG 51R: GGAGCTCCACAGAGTGTTCC
GAPDH (NM_009386.2) F: CGAGGCATCATCCCAAATAAGAAC 58.7R: TCCAGAAGTCTGCCCGATCAC
2.6. ELISA Detection of TSLP
ELISA capture assay was employed for the detection of pro-inflammatory cytokine TSLP in
accordance with the manufacturer’s instructions (e-Bioscience, San Diego, CA, USA). Supernatants
from HEK293 cells were collected after 6 h of treatment with Act d 1 (1 mg/mL). ELISA Maxisorp
immunoplates (Nunc™, Reskilde, Denmark) were employed for cytokine detection as previously
described [22].
2.7. NF-kB-GFP Reporter Assay
For transient transfection, HEK293 adherent cells with epithelial morphology were grown in T-75
flask (Nunc™ EasYFlask™ Cell Culture Flasks, Thermo Fisher Scientific, Waltham, MA, USA) and
cultivated in Minimum Essential Medium (MEM, Sigma-Aldrich, St. Louis, MO, USA) supplemented
with 10% heat-inactivated fetal bovine serum (FBS), penicillin (100 IU), and streptomycin (100 µg/mL)
(Sigma-Aldrich, St. Louis, MO, USA) and in 200 mM L-glutamine (Sigma-Aldrich, St. Louis, MO,
USA) in 5% CO2 at 37 ◦C. Before transfection, cells were passaged using 1 × trypsin/EDTA solution
(Sigma-Aldrich, St. Louis, MO, USA) and seeded in complete growth medium containing serum and
antibiotics in 96 well-plate (4 × 104 cells/well) or glass coverslips in 24-well plate (8 × 104 cells/well).
Cells were cultured until they reach ~80% confluence. On the day of transfection, 0.2 µg/well (or
0.4 µg/coverslip) of an appropriate DNA (Cignal NF-kB-GFP Pathway Reporter Assay Kit, Qiagen,
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Hilden, Germany) was diluted with medium without serum, antibiotics, and glutamine (Opti-MEM I
Reduced Serum Media, Thermo Fisher Scientific, Waltham, MA, USA) to a total volume of 50 µL/well
(60 µL/coverslip). Then, 0.75 µL/well (1.5 µL/coverslip) of Attractene Transfection Reagent (Qiagen,
Hilden, Germany) was added to the DNA solution mix and incubated for 20 min at RT. The medium
was replaced, and the transfection complex was added dropwise onto the cells. After 48 h of incubation,
cells were treated with activated and E-64 inactivated Act d 1 (1 mg/mL). Treatment was performed for
24 h at normal growth conditions. Activation of the NF-kB-GFP was assessed by flow cytometry and
by fluorescence microscopy.
For flow cytometry analysis, cells were detached with 1 × trypsin/EDTA solution (Sigma-Aldrich,
St. Louis, MO, USA), centrifuged (2000 rpm, 5 min), and resuspended in 1 × PBS. GFP fluorescence
intensity (104 events per sample) was measured using FACS Calibur (BD Biosciences, San Jose, CA,
USA). A blue solid-state 200-mW laser at 488 nm was used for excitation. The emission was detected
with a 525-nm filter (FL1). The positive cells were gated on the SSC, FL1H plot. Values were expressed
as the percentage of GFP fluorescence with respect to the negative control.
Act d 1 activation of NF-kB-GFP in transfected HEK293 cells was visualized by fluorescence
microscopy. Cells on coverslips were fixed with 4% paraformaldehyde (Fisher Scientific, Waltham,
MA, USA) in 1 × PBS for 15 min at RT. After washing with PBS (3×), cells were mounted on glass slides
and examined by a fluorescence microscope (Opto-Edu, Beijing, China). Images were acquired by an
objective with 60×magnification. For visualization, ImageView software was used and images were
further processed using Adobe Photoshop CS5 (Adobe Systems Incorporated, San Jose, CA, USA).
2.8. Statistical Analysis
All in vivo data analyzed by the Shapiro–Wilk test (n < 50) revealed normal distribution within
the groups. For in vivo permeability assay, independent t-test was employed. For gene expression
analysis two-way analysis of variance (ANOVA) with a Bonferroni post hoc test to adjust the p-value
for multiple comparisons was used. One-way ANOVA was used for ELISA and transfection assay.
The results were considered statistically significant if p < 0.05. The analysis was performed using
GraphPad Prism 5.0 (GraphPad, La Jolla, CA, USA).
3. Results
3.1. In Vivo Exposure to Act d 1 Leads to Increased Intestinal Permeability in C57BL/6 Mice
Proteolytic activity of Act d 1 preparation was tested in a protease enzymatic assay with casein as
a substrate (Figure 1). Four samples of Act d 1 were analyzed: (a) Act d 1, (b) Act d 1 activated in the
phosphate buffer pH 6.6 with L-cysteine, (c) Act d 1 activated in the cell culture medium, and (d) Act
d 1 inactivated with E-64 inhibitor. Act d 1 revealed 55% of caseinolytic activity when compared to
Act d 1 activated with L-cysteine (100%) and with Act d 1 activated with cell culture medium (98%).
The proteolytic activity of the E-64-inhibited sample of Act d 1 was undetectable in the assay.
To test permeability in vivo, mice were orally challenged with β-lactoglobulin after Act d
1 treatment (Figure 2). Act d 1 induced an increase in intestinal permeability since increased levels
of BLG were detected in sera of mice treated with activated Act d 1 but not of mice treated with
E64-inactivated Act d 1.
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Figure 2. Act d 1, but not inactivated Act d 1, increased intestinal permeability in C57BL/6 mice. At 24 h 
after oral administration of Act d 1 or inactivated Act d 1 (0.35 mL, 5 mg/mL), mice were orally 
administered with β-lactoglobulin (BLG; 500 mg/kg BW). Thirty minutes after BLG gavage, sera were 
collected to analyze the presence of BLG. Sample means of the three mice groups were compared using 
an independent t-test; n = 6 animals/group. * p < 0.05, compared to control. 
3.2. Act d 1 Differentially Upregulates mRNA Expression of TJ Proteins in Distinct Segments  
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ZO1 increased (Figure 3c). Clearly, Act d 1 remarkably changed the expression levels of TJ proteins in 
the proximal small intestine and in the colon. The mRNA expression of TJ proteins and E-cadherin 
remained almost unaffected in the distal small intestine. 
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Figure 2. Act d 1, but not inactivated Act d 1, increased intestinal permeability in C57BL/6 mice.
At 24 h after oral admi is ration of Act d 1 or inactivated Act d 1 (0.35 mL, 5 mg/mL), mice were orally
administered with β-lactoglobulin (BLG; 500 mg/kg BW). Thirty minutes after BLG gavage, s ra were
collected o analyze the presence of BLG. Sample means of the three mice groups were compared using
an independent t-test; n = 6 animals/group. * p < 0.05, compared to control.
3.2. Act d 1 Differentially Upregulates mRNA Expression of TJ Proteins in Distinct Segments of
Mouse Intestine
The effect of Act d 1 on TJ gene expression in vivo was analyzed by mRNA levels of CLDN1,
CLDN2, CLDN3, CLDN4, OCLN, ZO1, and E-cadherin in the proximal and distal small intestine and
in the colon. The expressions of CLDN2 and E-cadherin were remarkably increased in the proximal
part of the small intestine, while the expressions of CLDN4 and OCLN decreased (Figure 3a). In the
distal part of the intestine, CLDN1 and CLDN4 were decreased (Figure 3b). In the colon, CLDN1 and
CLDN2 expression were downregulated whereas the expressions of CLDN3, CLDN4, OCLN, and
ZO1 increased (Figure 3c). Clearly, Act d 1 remarkably changed the expression levels of TJ proteins in
the proximal small intestine and in the colon. The mRNA expression of TJ proteins and E-cadherin
remained almost unaffected in the distal small intestine.
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Figure 3. Effect of Act d 1 on mRNA expression of tight junction (TJ) proteins in different parts of the
mouse intestine: proximal small intestine (a), distal small intestine (b), and colon (c). Mice were orally
exposed to PBS (control), E64-inactivated Act d 1, and activated Act d 1. At 24 h, intestinal tissue was
dissected, homogenized and mRNA was isolated for qRT-PCR analysis. Results are expressed as mean
± SEM relative mRNA expression and analyzed using a two-way analysis of variance (ANOVA); n = 5
animals per group. * p < 0.05; ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, compared to control.
3.3. Act d 1 In uces Upregulation f mRNA for the te Pro-Allergenic Cytoki es in Vivo
To expl re the ability of Act d 1 t elicit an early inflammatory respo se, gene expression of
the pro-allergenic epithelial cell-derived cytokines IL-25, IL-33, and TSLP were measured in distinct
segments of mouse intestine (Figure 4). The level of TSLP mRNA was significantly increased in the
proximal small intestine (Figure 4a), whereas IL-25 and IL-33 mRNA were upregulated in the distal
part of mice intestine (Figure 4b). In the colon, the expression of TSLP was increased whereas IL-33
was downregulated (Figure 4c).
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Figure 4. Act d 1 induced upregulation of mRNA for the innate pro-allergenic cytokines in different
parts of the mouse intestine: (a) proximal small intestine, (b) distal small intestine, and (c) colon.
Mice were orally exposed to PBS (control), E-64 inactivated Act d 1, and activated Act d 1. After
24 h, intestinal tissue was dissected and homogenized and mRNA was isolated for qRT-PCR analysis.
Results are expressed as mean ± SEM relative mRNA expression; n = 5 animals per group. Results are
expressed as mean ± SEM and analyzed using a two-way analysis of variance (ANOVA). * p < 0.05; ***
p ≤ 0.001, **** p ≤ 0.0001, compared to control.
3.4. Act d 1 Affects HEK293 Monolayer Transepithelial Electrical Resistance
For enzyme activation, lyophilized Act d 1 was dissolved in cell culture medium and incubated
for 1 h while inactive enzyme was obtained by Act d 1 incubation with E-64 inhibitor. Effects of Act d 1
proteolytic activity on the HEK293 cell monolayers integrity was assessed by measuring transepithelial
electrical resistance (TEER) at 0 and 6 h of the treatment. Control cells maintain the basal TEER (98%)
over the 6 h period, while Act d 1 treatment reduced TEER to 75% of control (** p ≤ 0.01). The TEER of
monolayers exposed to E-64-inhibited Act d 1 was not significantly changed up to 6 h of treatment,
indicating that the observed effect was protease dependent (Figure 5).
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Figure 5. Active Act d 1 induced a decrease in transepithelial electrical resistance (TEER) values of
HEK293 monolayers. HEK293 cells were grown on inserts, and the effect of activated Act d 1 and
E64-inactivated Act d 1 on monolayer integrity was tested after 6 h. Results are expressed as mean
± SEM percentage of the initial value of three independent experiments performed in triplicate and
analyzed using a two-way analysis of variance (ANOVA); ** p ≤ 0.01 compared to the initial TEER
value (100%).
3.5. Act d 1 Activates the NF-kB Signaling Pathway and Upregulates the Innate Pro-Allergenic Cytokines
In Vitro
Act d 1 activation of NF-kB signaling in transfected HEK293 cells was detected as induced GFP
expression by flow cytometry (Figure 6 ) and fluorescence microscopy (Figure 6B) in comparison to
negative control and E-64-inactivated Act d 1.Biomolecules 2019, 9, x FOR PEER REVIEW 9 of 13 
 
(A) 
 
(B) 
Figure 6. (A), Quantification of GFP fluorescence as a consequence of NF-ĸB signaling in HEK293 cells 
upon Act d 1 treatment: HEK293 cells were transiently transfected with NF-ĸB-GFP plasmid for 48 h 
and, thereafter, were stimulated with activated and inactivated Act d 1. GFP expression was evaluated 
by flow cytometry after 24 h. The cell population was gated using SSC versus FL1-H dot plot and then 
represented as a histogram plot. Values are presented as mean ± SEM and analyzed using a one-way 
analysis of variance (ANOVA). * p < 0.05, compared to control. (B) Visualization of Act d 1-induced 
activation of NF-ĸB signaling by detecting GFP expression with fluorescence microscopy: HEK293 
cells were grown on glass coverslips, transfected with NF-ĸB-GFP plasmid, and treated with Act d 1 
(activated or E-64 inactivated). After fixation, cells were mounted on glass slides and examined by 
fluorescence microscopy. 
In addition, Act d 1-treated HEK239 cells provided evidence for the upregulation of mRNA 
expression for the innate pro-allergenic cytokines IL-25 and TSLP (Figure 7). 
Figure 6. (A), Quantification of GFP fluorescence as a consequence of NF-kB signaling in HEK293 cells
upon Act d 1 treatment: HEK293 cells were transiently transfected with NF-kB-GFP plasmid for 48 h
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and, thereafter, were stimulated with activated and inactivated Act d 1. GFP expression was evaluated
by flow cytometry after 24 h. The cell population was gated using SSC versus FL1-H dot plot and then
represented as a histogram plot. Values are presented as mean ± SEM and analyzed using a one-way
analysis of variance (ANOVA). * p < 0.05, compared to control. (B) Visualization of Act d 1-induced
activation of NF-kB signaling by detecting GFP expression with fluorescence microscopy: HEK293
cells were grown on glass coverslips, transfected with NF-kB-GFP plasmid, and treated with Act d 1
(activated or E-64 inactivated). After fixation, cells were mounted on glass slides and examined by
fluorescence microscopy.
In addition, Act d 1-treated HEK239 cells provided evidence for the upregulation of mRNA
expression for the innate pro-allergenic cytokines IL-25 and TSLP (Figure 7).
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Figure 7. Act d 1 induced the upregulation of mRNA for the innate pro-allergenic cytokines in vitro.
HEK293 cells were treated with activated Act d 1 or E-64-inactivated Act d 1. Results are expressed as
mean ± SEM and analyzed using a two-way analysis of variance (ANOVA). ** p ≤ 0.01, **** p ≤ 0.0001,
compared to control.
ELISA was employed to explore the effect of Act d 1 on HEK293 epithelial cells in terms of the
production of pro-inflammatory cytokines. The 6-h treatment induced a significant release of TSLP
(Figure 8).
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4. Discussion
Disruption of the intestinal barrier has been associated with food allergy [23]. This is especially
the case with food proteases, which are capable of inducing changes in the morphology of the epithelial
barrier and of affecting intestinal permeability [19,24]. Act d 1 is an abundant allergen in kiwifruit that
preserves its proteolytic activity in the intestine [19,25]. Experimental data indicates that Act d 1 could
exert direct proteolytic cleavage of the tight junction proteins [19]. The molecular mechanism behind
this effect has not been clarified.
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In this study, increased intestinal permeability to BLG was observed in mice after oral
administration of active Act d 1. These findings are in consistence with our previous results on
increased permeability of the mouse intestine for 40 kDa FITC-dextran upon Act d 1 treatment [19]
and with other studies showing an increase in epithelial permeability and disruption of the TJs [26].
Tight junctions provide cell-to-cell adhesion in enterocytes and play a key role in the regulation of
the barrier permeability, which varies in different segments of the intestines [27,28]. Three types
of transmembrane proteins are in common to all TJs: claudins, MARVEL domain proteins, and
junctional adhesion molecules (JAMs). Among those transmembrane proteins, occludin (OCLN)
and claudins (CLDNs) form a barrier at the apical-lateral membrane of the cell while peripheral
membrane proteins, like zonula occludens (ZO) proteins, serve as a link between the transmembrane
TJ proteins and the cytoskeleton [29]. Claudins form selective pores for the paracellular transport and,
hence, are the most important proteins involved in the permeability of the intestinal barrier [30,31].
By immunofluorescence staining, it was shown that CLDN1, −3, and −4 are dominantly expressed in
the colon while CLDN2 is predominantly expressed in the small intestine of mice [23]. In addition,
CLDN2 is the main pore-forming protein and its expression is strongly upregulated in the duodenal
biopsies of patients with food allergy [27,32,33]. Our results clearly demonstrate that mRNA expression
of CLDN2 and E-cadherin in the proximal small intestine of mice is significantly upregulated upon Act
d 1 administration. This could be a compensatory effect, which is an indication of the altered integrity
of the intestinal epithelial cell layer [34].
Expression of CLDN1 was previously found to be decreased in the distal small intestine of patients
with food allergy [27,35]. Our findings are in line with this observation and show that expression of
CLDN1 was downregulated both in the distal small intestine and in the colon upon Act d 1 treatment.
mRNA expressions of CLDN4, OCLN, and ZO1 were significantly decreased in the proximal part of
the small intestine, while mRNA expressions of CLDN1 and CLDN4 were downregulated in the distal
small intestine. In the colon, the opposite effect was observed, with increased expressions of CLDN3,
CLDN4, OCLD, and ZO1 and decreased CLDN2 expression. Overall, our results from the in vivo
study indicate the claudin family of TJs as the most affected by Act d 1 treatment in the proximal small
intestine and in the colon.
The epithelium is crucial for the initiation and orchestration of immune responses leading to
sensitization to allergens. This includes secretion of pro-allergenic cytokines such as IL-33, IL-25, and
TSLP [14,36]. In this study, we found that depending on the location in the intestine, IL-33, IL-25, and
TSLP mRNA were increased after administration of Act d 1.
The role of food proteases in the development of Th2 immune response correlates with increased
IL-25 and TSLP gene expression [37]. By employing an in vitro model HEK293 cell system, we showed
that Act d 1 can affect the integrity of HEK293 epithelial cell monolayer and decrease TEER. Act d 1
upregulates the mRNA expression of IL-25 and TSLP but also activates the NF-kB signaling pathway.
In HEK293 cells, proteolytically active Act d 1 induced secretion of TSLP, an important gut epithelial
cytokine, which can activate Th2 cells.
5. Conclusions
In summary, we provide a model where exposure of the mouse intestine to a food proteolytic
enzyme compromised the integrity of the epithelial barrier and mediated upregulation of pro-Th2
cytokines, possibly via NF-kB. Increased epithelial permeability in the gastrointestinal tract is a risk
factor for various antigens from the lumen to reach the submucosa and to induce inflammation. These
findings provide evidence that food proteins with proteolytic activity can trigger innate immunity.
Improvement of the mechanistic understanding of food allergy should pave a way for the better
management of food allergies. The importance of these findings is a better insight into molecular
events that contribute to the breakdown of clinical and immunological tolerance to kiwifruit, allowing
the design of future therapeutic approaches in the management of food allergy.
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